Aromatherapy Inhalation in Psychiatric Nurses
- Conditions
- Aromatherapy
- Registration Number
- NCT06761859
- Lead Sponsor
- SERDAR TÜRKYILMAZ
- Brief Summary
In this study will be conducted with a total of 66 psychiatric nurses who meet the inclusion and exclusion criteria and are working at Ankara Etlik City Hospital Psychiatry Clinic between January 1, 2025 and March 31, 2025.
- Detailed Description
In this study, aromatherapy inhalation will be applied to psychiatric nurses in the experimental group. Aromatherapy inhalation using 2% diluted lavender essential oil will be applied to 33 psychiatric nurses in the experimental group, 30 minutes before starting work, every other day during a week. The "General Job Stress Scale (GJSS)" and "Therapeutic Relationship Evaluation Scale-Nurse Form (TRES-NF)" inventories will be filled out by 33 psychiatric nurses in the experimental group before and after aromatherapy inhalation, and by 33 psychiatric nurses in the control group simultaneously with the psychiatric nurses in the experimental group.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 66
- Written permission was obtained before participating in the study
- Having worked in the psychiatry departments of the relevant institution for at least 1 year
- Working in the psychiatry departments of the relevant institution during the study dates
- Not sensitive to the odor of lavender essential oil
- Previous experience with aromatherapy
- Sensitivity and allergy to lavender essential oil
- Willingly leaving the study while the study was ongoing
- Leaving the job during the study period
- General condition changes during the study period (developing allergies, getting sick, taking annual leave, taking leave with a health report)
- Becoming a service responsible nurse
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method General Job Stress Scale (GJSS) Change from before implementation, after practice is completed (1th week) The Turkish validity and reliability of the scale developed by De Bruin (2006) to measure the general job stress of employees was provided by Teleş (2020). The scale has a one-dimensional structure that addresses the emotional, cognitive, motivational and social consequences of job stress. The scale, which has no sub-dimensions and consists of a five-point Likert-type and nine items, is stated as "1=Never, 2=Rarely, 3=Sometimes, 4=Mostly, 5=Always". The total score to be obtained from the scale is a concrete expression of job stress and a high score to be obtained from the scale indicates that high job stress is experienced. As a result of the validity and reliability study conducted by Teleş (2020), the Cronbach alpha coefficient of the scale was stated as 0.91 (De Bruin, 2006; Teleş, 2020).
Therapeutic Relationship Evaluation Scale-Nurse Form (TRES-NF) Change from before implementation, after practice is completed (1th week) Developed by Coelho et al. (2021) to assess the quality of the therapeutic relationship between psychiatric nurses and psychiatric patients, the Turkish validity and reliability of the scale was established by Duran and Polat (2023). The scale, which consists of a five-point Likert type and 25 items, can be used in one dimension or with four subdimensions as "empathy, self-awareness, participation in care, and orientation". The answers to each item in the scale are specified as "1=Never, 2=Rarely, 3=Sometimes, 4=Frequently, 5=Always". It has been stated that a minimum of 25 and a maximum of 125 points can be obtained if the scale is used in one dimension. It has been stated that if the scale is used in other subdimensions, 5-25 points can be obtained from the empathy subdimension, 6-30 from the self-awareness subdimension, 8-40 from the participation in care subdimension, and 6-30 from the orientation subdimension. As a result of their validity and reliability study, Duran and Polat (
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Ankara Etlik City Hospital
🇹🇷Ankara, Yenimahalle, Turkey